LAMIVUDINE
Generic: LAMIVUDINE
Apotex Corp.Manufacturer
ORALRoute
LAMIVUDINEActive Substance
2014-01-02Original Approval
LAMIVUDINE is FDA application ANDA202941, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
VIROLOGIC FAILURE
1,968 reports
2
FOETAL EXPOSURE DURING PREGNANCY
1,963 reports
3
DRUG RESISTANCE
1,910 reports
4
DRUG INTERACTION
1,810 reports
5
PATHOGEN RESISTANCE
1,803 reports
6
VIRAL MUTATION IDENTIFIED
1,711 reports
7
DRUG INEFFECTIVE
1,101 reports
8
DEPRESSION
1,070 reports
9
TREATMENT FAILURE
1,033 reports
10
PYREXIA
989 reports